July 28 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* Valeant has increased size of its board to 12 members, 11 of whom are independent
* Valeant Pharmaceuticals announces the addition of Sarah B. Kavanagh to its board of directors
* Valeant Pharmaceuticals announces the addition of Sarah B. Kavanagh to its board of directors Source text for Eikon: ID:nCNWQhT2Va Further company coverage: VRX.TO
(Bengaluru Newsroom: +1-646-223-8780)